Video Experimental Relacionado
Updated: Jan 7, 2026

10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.4K
Orientación de IL-18 altamente atenuado a PD-1 para una mayor actividad antitumoral
Xueyuan Zhou1, Felix Klaus Geyer2, Jeffrey Takimoto1
1Drug Discovery and Development, Fuse Biotherapeutics, Woburn, MA, United States.
Frontiers in immunology
|January 5, 2026
Resumen
No abstract available in PubMed .

